[
  {
    "info": {
      "NCT": "NCT04913285",
      "Protocol_No": "KN-8701",
      "jit": "Caris",
      "trial_name": "Kinnate Biopharma KN-8701 "
    },
    "disease": {
      "summary": "Solid Tumor, Adult | Non-small Cell Lung Cancer | Melanoma",
      "details": [
        {
          "code": "Melanoma (MEL)",
          "selection": "include",
          "stage": "Metastatic;Advanced Stage"
        },
        {
          "code": "Non-Small Cell Lung Cancer (NSCLC)",
          "selection": "include",
          "stage": "Metastatic;Advanced Stage"
        },
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Metastatic;Advanced Stage"
        }
      ]
    },
    "query": {
      "nct": "NCT04913285",
      "title": "A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors",
      "current_status": "Recruiting",
      "status_verif_date": "August 2022",
      "last_update_date": "August 31, 2022",
      "trial_hold_status": "open",
      "sponsor": "Kinnate Biopharma",
      "brief_summary": "The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated advanced or metastatic solid tumors.",
      "conditions": "Solid Tumor, Adult | Non-small Cell Lung Cancer | Melanoma",
      "type": "Interventional",
      "phase": "Phase 1",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Dose Escalation Monotherapy (Part A1)",
          "drug": "KIN-2787",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Dose Escalation Monotherapy (Part A1)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class I Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class I Mutation positive  "
            },
            {
              "cohort": "Dose Escalation Monotherapy (Part A1)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class II Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class II Mutation positive  "
            },
            {
              "cohort": "Dose Escalation Monotherapy (Part A1)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class III Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class III Mutation positive  "
            },
            {
              "cohort": "Dose Escalation Monotherapy (Part A1)",
              "Gene": "NRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "NRAS Mutation positive  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Dose Escalation Combination therapy (Part A2)",
          "drug": "KIN-2787 and binimetinib",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Dose Escalation Combination therapy (Part A2)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class I Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class I Mutation positive  "
            },
            {
              "cohort": "Dose Escalation Combination therapy (Part A2)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class II Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class II Mutation positive  "
            },
            {
              "cohort": "Dose Escalation Combination therapy (Part A2)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class III Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class III Mutation positive  "
            },
            {
              "cohort": "Dose Escalation Combination therapy (Part A2)",
              "Gene": "NRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "NRAS Mutation positive  "
            }
          ]
        },
        {
          "ArmID": "3",
          "cohortlabel": "Dose Expansion (Part B)",
          "drug": "KIN-2787",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Dose Expansion (Part B)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class II Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class II Mutation positive  "
            },
            {
              "cohort": "Dose Expansion (Part B)",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Class III Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "BRAF Class III Mutation positive  "
            },
            {
              "cohort": "Dose Expansion (Part B)",
              "Gene": "NRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "positive",
              "summary": "NRAS Mutation positive  "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-20",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04913285\" target=\"_blank\">NCT04913285<\/a>"
    }
  }
]
